BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Cho WJ, Jin AT, Kok LY, Shi Y, Heller DE, Lee YL, Zhou Y, Xie X, Korzenik JR, Lennerz JK, Traverso G. Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine. Adv Healthc Mater 2020;9:e2000536. [PMID: 32597571 DOI: 10.1002/adhm.202000536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Yu M, Yang H. Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease. J Inflamm Res 2021;14:1701-16. [PMID: 33953597 DOI: 10.2147/JIR.S304101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vitulo M, Gnodi E, Meneveri R, Barisani D. Interactions between Nanoparticles and Intestine. IJMS 2022;23:4339. [DOI: 10.3390/ijms23084339] [Reference Citation Analysis]
3 Ren Q, Sun S, Zhang X. Redox-active nanoparticles for inflammatory bowel disease. Nano Res 2021;14:2535-57. [DOI: 10.1007/s12274-021-3303-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang L, Liao Y, Yang R, Zhu Z, Zhang L, Wu Z, Sun X. An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis. Bioeng Transl Med 2021;6:e10219. [PMID: 34589596 DOI: 10.1002/btm2.10219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Min K, Yoo S, Han MS, Tae G. Effective and prolonged targeting of a nanocarrier to the inflammation site by functionalization with ZnBPMP and chitosan. Mater Sci Eng C Mater Biol Appl 2021;131:112521. [PMID: 34857300 DOI: 10.1016/j.msec.2021.112521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]